MPH Health Care

Earnings Release • May 23, 2013

News Details

Corporate | 23 May 2013 08:15

MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT

MPH Mittelständische Pharma Holding AG / Key word(s): Quarter Results/Development of Sales

23.05.2013 / 08:15

---

MPH Mittelständische Pharma Holding AG:

1 st Quarter 2013: +31.4% in Sales; +34.3% in EBIT

For the first three months of the current year, the Group is reporting sales of EUR 53.42 million, with thus representing an increase of 31.4 % compared to the same period of the previous year (prior-year period: EUR 40.66 million). The consolidated profit before interests and taxes (EBIT) for January through March 2013, at EUR 4.15 million, was 34.3 % above the prior-year level (EUR 3.09 million). An EBIT margin of 7.8% was achieved.

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on growth segments Pharma and Healthcare. On the basis of patent-free and patent-protected active substances, production and consultancy services for therapies of chronic diseases, the Group makes a precious contribution to keeping health affordable.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 41.167.155

Listed shares: Preference shares

Number of preference shares in circulation: 19.025.000

ISIN: DE000A0NF697

WKN: A0NF69

Stock symbol: 93MV

Contact:

Linda Reichelt

MPH Mittelständische Pharma Holding AG

Fasanenstraße 77

D-10623 Berlin

Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308670

E-Mail: ir@mph-ag.de Web: www.mph-ag.de

End of Corporate News

---

23.05.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	MPH Mittelständische Pharma Holding AG
	Fasanenstraße 77
	10623 Berlin
	Germany
Phone:	030 / 897 308 660
Fax:	030 / 897 308 670
E-mail:	info@mph-ag.de
Internet:	www.mph-ag.de
ISIN:	DE000A0NF697
WKN:	A0NF69
Listed:	Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard)

End of News	DGAP News-Service

- - -
212404  23.05.2013